Raburn M Mallory

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
  2. doi request reprint Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
    Raburn M Mallory
    MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
    Vaccine 29:4322-7. 2011
  3. ncbi request reprint Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*
    Eric A Sheldon
    Rheumatology and Internal Medicine, Miami Research Associates, Miami, FL, USAInternal Medicine, Benchmark Research, Metairie, LA, USAVanda Pharmaceuticals, Inc, Washington, DC, USAi3Statprobe, Clarksburg, MD, USAComparative Effectiveness Research, GlaxoSmithKline, Research Triangle Park, NC, USAClinical Development, MedImmune, LLC, Gaithersburg, MD, USA
    Influenza Other Respir Viruses 7:1142-50. 2013
  4. doi request reprint The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
    Christopher S Ambrose
    MedImmune, LLC, Gaithersburg, MD 20878, USA
    Vaccine 30:6794-801. 2012

Collaborators

Detail Information

Publications4

  1. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
    ..The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults...
  2. doi request reprint Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
    Raburn M Mallory
    MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
    Vaccine 29:4322-7. 2011
    ..The incidence, duration, and other parameters of viral shedding after vaccination with LAIV have not been fully described in children ≤ 5 years of age...
  3. ncbi request reprint Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*
    Eric A Sheldon
    Rheumatology and Internal Medicine, Miami Research Associates, Miami, FL, USAInternal Medicine, Benchmark Research, Metairie, LA, USAVanda Pharmaceuticals, Inc, Washington, DC, USAi3Statprobe, Clarksburg, MD, USAComparative Effectiveness Research, GlaxoSmithKline, Research Triangle Park, NC, USAClinical Development, MedImmune, LLC, Gaithersburg, MD, USA
    Influenza Other Respir Viruses 7:1142-50. 2013
    ..An Ann Arbor strain quadrivalent live attenuated influenza vaccine (Q/LAIV) containing B strains from both lineages is being developed to address this issue...
  4. doi request reprint The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
    Christopher S Ambrose
    MedImmune, LLC, Gaithersburg, MD 20878, USA
    Vaccine 30:6794-801. 2012
    ..The role of IgA in providing protection against influenza in children vaccinated with live attenuated influenza vaccine (LAIV) has not been well described...